RecruitingNCT06889805
HDV Screening Study
Universal Screening for Hepatitis Delta Virus (HDV) in Individuals Living with HIV/HBV Coinfection and HBV-related HCC
Sponsor
Grace Lai Hung Wong
Enrollment
300 participants
Start Date
Feb 15, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study screens people who are already living with both HIV and chronic hepatitis B for a third virus called hepatitis D (HDV). Hepatitis D can only infect people who have hepatitis B, and it can make liver disease much worse. The study aims to understand how common HDV is in this population.
**You may be eligible if...**
- You are 18 or older
- You are HIV-positive (confirmed by antibody or RNA test)
- You have chronic hepatitis B (confirmed by surface antigen or DNA positive on two tests at least 6 months apart)
- You are willing to provide consent
**You may NOT be eligible if...**
- You are under 18
- You refuse to consent to the screening
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06889805